Meredith Chuk, M.D.

Medical Officer, Sarcoma/Melanoma Team, Division of Oncology Products 2; Scientific Liaison, Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Dr. Chuk is a medical officer on the sarcoma/melanoma team in the Division of Oncology Products 2 in the Office of Hematology and Oncology Products (OHOP) in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. She also serves as the OHOP Scientific Liaison for sarcoma, and in this role interacts with investigators and patient advocates with the goal of furthering drug development for new agents in sarcoma.

Prior to joining the FDA, Dr. Chuk was an assistant professor of pediatrics at the Children’s Hospital of Pittsburgh in the Department of Hematology/Oncology. She completed a pediatric hematology/oncology fellowship at the Johns Hopkins/National Cancer Institute fellowship program, a master’s degree in clinical research through Duke University, and obtained her medical degree from the Pennsylvania State University College of Medicine.